Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

Saved in:
Bibliographic Details
Title: Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.
Authors: Cardet JC; Department of Medicine, Brigham and Women's Hospital, Boston, Mass., Jiang X; Departments of Environmental Health, Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Mass., Lu Q; Departments of Environmental Health, Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Mass., Gerard N; Department of Pediatrics, Boston Children's Hospital, Boston, Mass., McIntire K; Department of Medicine, Brigham and Women's Hospital, Boston, Mass., Boushey HA; Department of Medicine, University of California San Francisco, San Francisco, Calif., Castro M; Department of Medicine, Washington University, St Louis, Mo., Chinchilli VM; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa., Codispoti CD; Department of Medicine, Rush University Medical Center and Department of Pediatrics, Stroger Hospital of Cook County, Chicago, Ill., Dyer AM; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa., Holguin F; Department of Medicine, Pittsburgh University, Pittsburgh, Pa., Kraft M; Department of Medicine, University of Arizona, Tucson, Ariz., Lazarus S; Department of Medicine, University of California San Francisco, San Francisco, Calif., Lemanske RF; Departments of Medicine and Pharmacy Practice, University of Wisconsin, Madison, Wis., Lugogo N; Department of Medicine, Duke University, Durham, NC., Mauger D; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa., Moore WC; Department of Internal Medicine, Wake Forest University, Winston-Salem, NC., Moy J; Department of Medicine, Rush University Medical Center and Department of Pediatrics, Stroger Hospital of Cook County, Chicago, Ill., Ortega VE; Department of Internal Medicine, Wake Forest University, Winston-Salem, NC., Peters SP; Department of Internal Medicine, Wake Forest University, Winston-Salem, NC., Smith LJ; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill., Solway J; Department of Medicine, University of Chicago, Chicago, Ill., Sorkness CA; Departments of Medicine and Pharmacy Practice, University of Wisconsin, Madison, Wis., Sumino K; Department of Medicine, Washington University, St Louis, Mo., Wechsler ME; Department of Medicine, National Jewish University, Denver, Colo., Wenzel S; Department of Medicine, Pittsburgh University, Pittsburgh, Pa., Israel E; Department of Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: eisrael@bwh.harvard.edu.
Corporate Authors: AsthmaNet Investigators
Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Aug; Vol. 144 (2), pp. 416-425.e7. Date of Electronic Publication: 2019 Mar 11.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6825
DOI:10.1016/j.jaci.2019.01.049